Skip To Main Content

Genesys Ventures III

Electronic Circuitry
  • Home 
  • Genesys Ventures III

Identified through a call for expressions of interest from qualified managers to establish a new life sciences venture capital fund, Venture Ontario selected the Genesys team as a leading candidate and committed $17 million to the Genesys Ventures III LP.

Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities.

Portfolio

Adapsyn logo
Fairhaven logo
Fusion Pharmaceuticals logo
Inversago logo
Profound Medical logo
Genesys Capital (Fund Manager) logo